PMID- 26159310
OWN - NLM
STAT- MEDLINE
DCOM- 20151026
LR  - 20220316
IS  - 1560-7917 (Electronic)
IS  - 1025-496X (Linking)
VI  - 20
IP  - 26
DP  - 2015 Jul 2
TI  - Current prevalence of multidrug-resistant organisms in long-term care facilities 
      in the Rhine-Main district, Germany, 2013.
LID - 21171 [pii]
AB  - Multidrug-resistant organisms (MDRO) and in particular multidrug-resistant 
      Gram-negative organisms (MRGN) are an increasing problem in hospital care. 
      However, data on the current prevalence of MDRO in long-term care facilities 
      (LTCFs) are rare. To assess carriage rates of MDRO in LTCF residents in the 
      German Rhine-Main region, we performed a point prevalence survey in 2013. Swabs 
      from nose, throat and perineum were analysed for meticillin-resistant 
      Staphylococcus aureus (MRSA), perianal swabs were analysed for extended-spectrum 
      beta-lactamase (ESBL)-producing organisms, MRGN and vancomycin-resistant 
      enterococci (VRE). In 26 LTCFs, 690 residents were enrolled for analysis of MRSA 
      colonisation and 455 for analysis of rectal carriage of ESBL/MRGN and VRE. 
      Prevalences for MRSA, ESBL/MRGN and VRE were 6.5%, 17.8%, and 0.4%, respectively. 
      MRSA carriage was significantly associated with MRSA history, the presence of 
      urinary catheters, percutaneous endoscopic gastrostomy tubes and previous 
      antibiotic therapy, whereas ESBL/MRGN carriage was exclusively associated with 
      urinary catheters. In conclusion, this study revealed no increase in MRSA 
      prevalence in LTCFs since 2007. In contrast, the rate of ESBL/MRGN carriage in 
      German LTCFs was remarkably high. In nearly all positive residents, MDRO carriage 
      had not been known before, indicating a lack of screening efforts and/or a lack 
      of information on hospital discharge.
FAU - Hogardt, M
AU  - Hogardt M
AD  - Institute for Medical Microbiology and Infection Control, University Hospital, 
      Goethe-University, Frankfurt am Main, Germany.
FAU - Proba, P
AU  - Proba P
FAU - Mischler, D
AU  - Mischler D
FAU - Cuny, C
AU  - Cuny C
FAU - Kempf, V A
AU  - Kempf VA
FAU - Heudorf, U
AU  - Heudorf U
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20150702
PL  - Sweden
TA  - Euro Surveill
JT  - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European 
      communicable disease bulletin
JID - 100887452
RN  - 0 (Anti-Bacterial Agents)
RN  - EC 3.5.2.6 (beta-Lactamases)
SB  - IM
MH  - Anti-Bacterial Agents/therapeutic use
MH  - Bacteria/drug effects/isolation & purification
MH  - Bacterial Infections/*epidemiology/microbiology
MH  - Cross Infection/*epidemiology/microbiology
MH  - *Drug Resistance, Multiple, Bacterial
MH  - Female
MH  - Germany/epidemiology
MH  - *Health Facilities
MH  - Humans
MH  - Long-Term Care
MH  - Male
MH  - Methicillin-Resistant Staphylococcus aureus/drug effects/*isolation & 
      purification
MH  - Nose/microbiology
MH  - Oropharynx/microbiology
MH  - Prevalence
MH  - Rectum/microbiology
MH  - Risk Factors
MH  - Vancomycin Resistance
MH  - Vancomycin-Resistant Enterococci/drug effects/*isolation & purification
MH  - beta-Lactamases
EDAT- 2015/07/15 06:00
MHDA- 2015/10/27 06:00
CRDT- 2015/07/11 06:00
PHST- 2015/07/11 06:00 [entrez]
PHST- 2015/07/15 06:00 [pubmed]
PHST- 2015/10/27 06:00 [medline]
AID - 21171 [pii]
AID - 10.2807/1560-7917.es2015.20.26.21171 [doi]
PST - epublish
SO  - Euro Surveill. 2015 Jul 2;20(26):21171. doi: 
      10.2807/1560-7917.es2015.20.26.21171.